• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WRIGHTS LANE SYNTHES USA PRODUCTS LLC; APPLIANCE, FIXATION, NAIL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WRIGHTS LANE SYNTHES USA PRODUCTS LLC; APPLIANCE, FIXATION, NAIL Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Unspecified Infection (1930); Necrosis (1971); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
This report is for an unknown delta external fixation frame/unknown lot.Part and lot number are unknown; udi number is unknown.Date of implantation is an unknown date between (b)(6) 1991 and (b)(6) 1996.Complainant part is not expected to be returned for manufacturer review/investigation.Without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.(b)(4).Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.(b)(4).
 
Event Description
This report is being filed after the review of the following journal article: sirkin m, sanders r, dipasquale t, herscovici d (2004).A staged protocol for soft tissue management in the treatment of complex pilon fractures.Journal of orthopaedic trauma.Volume 18.Number 8 supplement.S32-s38.(usa).Between january 1991 and december 1996, 53 patients (56 fractures) with complex pilon fractures who underwent a staged protocol for soft tissue management were included in the study.There were 36 males and 17 females with a mean age of 37 years (range, 21 to 74 years).Fractures were divided into 2 groups: closed and open injuries.Group i consisted of 34 closed fractures and group ii was composed of 22 open fractures.All fibular fractures were initially treated with either an unknown synthes one-third tubular plate or an unknown synthes 3.5mm dynamic compression plate, depending on the fracture pattern.After completing the initial fibular fracture fixation, the 32 fractures were applied with an unknown synthes delta external fixation frame while the other 24 fractures were applied with a competitor¿s external fixator.Patients were followed until soft tissue swelling disappears to have the surgery performed, generally within 7 to 14 days postinjury.Tibial fixation was then obtained using unknown synthes cloverleaf plate in 48 fractures.In 12 fractures, the unknown synthes cloverleaf plate was augmented anteriorly with a 2 or 3-hole unknown synthes one-third tubular plate.In 8 fractures, they were treated medially with a one-third tubular plate (2 fractures), an unknown synthes 4.5mm dynamic compression plate (3 fractures), an unknown synthes t plate (1 fracture), or an unknown synthes 3.5mm dynamic compression plate (2 fractures).When internal fixation was completed, the external fixator pins are removed, and the pin sites are irrigated and curetted.The patients were then placed in a bulky soft dressing with a posterior splint.Patients were followed-up at 3 weeks after discharge.The patients were instructed with a range of motion activities but were not permitted weight bearing until radiographic healing occurred.All patients were followed for a minimum of 12 months postoperatively, and all wound problems were recorded.The authors did not specify which of the synthes plates were used for these patients.Thus, complications will be reported as follows: (group i, closed pilon) 5 limbs had initial partial-thickness skin necrosis.All were treated with local wound care and oral antibiotics when appropriate.1 patient had chronic draining sinus secondary to osteomyelitis which resolved after fracture healing and metal removal.The hardware was removed, the tibia was superficially debrided, and the osteomyelitis and drainage resolved.The patient eventually required an ankle fusion 2 years after the injury for post-traumatic arthritis.(group ii, open pilon): 2 patients had initial partial-thickness skin necrosis.All were treated with local wound care and oral antibiotics when appropriate.1 patient had wound dehiscence with subsequent osteomyelitis necessitating multiple debridements.The patient was placed on intravenous antibiotics and required hardware removal and re-application of an external fixator.The wounds healed, and the infection was eradicated.1 patient developed severe osteomyelitis in multiple sites in this lower limb and required amputation 5 months post-injury.This report is for an unknown synthes delta external fixation frame.This is report 7 of 7 for (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
APPLIANCE, FIXATION, NAIL
Manufacturer (Section D)
WRIGHTS LANE SYNTHES USA PRODUCTS LLC
1302 wrights lane east
west chester PA 19380
Manufacturer Contact
kara ditty-bovard
1302 wrights lane east
west chester, PA 19380
6103142063
MDR Report Key8616028
MDR Text Key145251704
Report Number2939274-2019-58099
Device Sequence Number1
Product Code KTT
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 04/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/17/2019
Initial Date FDA Received05/16/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-